Onitilo, Adedayo A.Doi, SuhailEngel, Jessica M.Glurich, IngridBerg, Richard2016-06-140049-3848http://hdl.handle.net/1885/102699Keywords: blood clotting factor 5 Leiden; tamoxifen; blood clot; body mass; breast cancer; cancer staging; deep vein thrombosis; disease association; gene mutation; human; letter; priority journal; venous thromboembolism; Antineoplastic Agents, Hormonal; Breast NeoRelationship between Factor V Leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen201310.1016/j.thromres.2013.01.0352016-06-14